A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction

医学 内科学 射血分数保留的心力衰竭 射血分数 心脏病学 心力衰竭 队列 介绍 心肌病 回顾性队列研究 逻辑回归 弗雷明翰风险评分 疾病 家庭医学
作者
Daniel R. Davies,Margaret M. Redfield,Christopher G. Scott,Masatoshi Minamisawa,Martha A. Grogan,Angela A. Dispenzieri,Panithaya Chareonthaitawee,Amil M. Shah,Sanjiv Jayendra Shah,Ramsey M. Wehbe,Scott David Solomon,Yogesh N.V. Reddy,Barry A. Borlaug,Omar F. AbouEzzeddine
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:7 (10): 1036-1036 被引量:139
标识
DOI:10.1001/jamacardio.2022.1781
摘要

Importance: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a form of heart failure (HF) with preserved ejection fraction (HFpEF). Technetium Tc 99m pyrophosphate scintigraphy (PYP) enables ATTR-CM diagnosis. It is unclear which patients with HFpEF have sufficient risk of ATTR-CM to warrant PYP. Objective: To derive and validate a simple ATTR-CM score to predict increased risk of ATTR-CM in patients with HFpEF. Design, Setting, and Participants: Retrospective cohort study of 666 patients with HF (ejection fraction ≥ 40%) and suspected ATTR-CM referred for PYP at Mayo Clinic, Rochester, Minnesota, from May 10, 2013, through August 31, 2020. These data were analyzed September 2020 through December 2020. A logistic regression model predictive of ATTR-CM was derived and converted to a point-based ATTR-CM risk score. The score was further validated in a community ATTR-CM epidemiology study of older patients with HFpEF with increased left ventricular wall thickness ([WT] ≥ 12 mm) and in an external (Northwestern University, Chicago, Illinois) HFpEF cohort referred for PYP. Race was self-reported by the participants. In all cohorts, both case patients and control patients were definitively ascertained by PYP scanning and specialist evaluation. Main Outcomes and Measures: Performance of the derived ATTR-CM score in all cohorts (referral validation, community validation, and external validation) and prevalence of a high-risk ATTR-CM score in 4 multinational HFpEF clinical trials. Results: Participant cohorts included were referral derivation (n = 416; 13 participants [3%] were Black and 380 participants [94%] were White; ATTR-CM prevalence = 45%), referral validation (n = 250; 12 participants [5%]were Black and 228 participants [93%] were White; ATTR-CM prevalence = 48% ), community validation (n = 286; 5 participants [2%] were Black and 275 participants [96%] were White; ATTR-CM prevalence = 6% ), and external validation (n = 66; 23 participants [37%] were Black and 36 participants [58%] were White; ATTR-CM prevalence = 39%). Score variables included age, male sex, hypertension diagnosis, relative WT more than 0.57, posterior WT of 12 mm or more, and ejection fraction less than 60% (score range -1 to 10). Discrimination (area under the receiver operating characteristic curve [AUC] 0.89; 95% CI, 0.86-0.92; P < .001) and calibration (Hosmer-Lemeshow; χ2 = 4.6; P = .46) were strong. Discrimination (AUC ≥ 0.84; P < .001 for all) and calibration (Hosmer-Lemeshow χ2 = 2.8; P = .84; Hosmer-Lemeshow χ2 = 4.4; P = .35; Hosmer-Lemeshow χ2 = 2.5; P = .78 in referral, community, and external validation cohorts, respectively) were maintained in all validation cohorts. Precision-recall curves and predictive value vs prevalence plots indicated clinically useful classification performance for a score of 6 or more (positive predictive value ≥25%) in clinically relevant ATTR-CM prevalence (≥10% of patients with HFpEF) scenarios. In the HFpEF clinical trials, 11% to 35% of male and 0% to 6% of female patients had a high-risk (≥6) ATTR-CM score. Conclusions and Relevance: A simple 6 variable clinical score may be used to guide use of PYP and increase recognition of ATTR-CM among patients with HFpEF in the community. Further validation in larger and more diverse populations is needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
悦耳语堂发布了新的文献求助10
刚刚
ximu518完成签到 ,获得积分10
刚刚
bkagyin的应助被安婷fly采纳,获得10
刚刚
忧郁寄瑶完成签到 ,获得积分10
1秒前
1秒前
冷酷的依瑶完成签到,获得积分10
1秒前
多情涵山完成签到 ,获得积分10
2秒前
枫叶游发布了新的文献求助10
2秒前
聪明的哈密瓜完成签到,获得积分10
2秒前
tttt发布了新的文献求助10
2秒前
灰灰完成签到 ,获得积分10
2秒前
2秒前
clement完成签到,获得积分10
3秒前
林中鸟完成签到,获得积分10
3秒前
3秒前
ding的应助被一颗椰子糖耶采纳,获得10
4秒前
星星完成签到,获得积分10
4秒前
4秒前
细腻的歌曲完成签到,获得积分10
4秒前
5秒前
鬼先生发布了新的文献求助10
6秒前
ZCF_Timme完成签到,获得积分10
6秒前
6秒前
Mint完成签到,获得积分10
6秒前
6秒前
六花完成签到,获得积分10
6秒前
莓莓发布了新的文献求助10
7秒前
刘大宝发布了新的文献求助10
7秒前
萌~Lucky完成签到,获得积分10
8秒前
9秒前
科研通AI6.3的应助被鬼先生采纳,获得10
9秒前
初景的应助被geold采纳,获得20
10秒前
汉堡包的应助被stanfordlee采纳,获得10
11秒前
kuku发布了新的文献求助10
11秒前
王悦靓发布了新的文献求助10
11秒前
无私尔风完成签到,获得积分10
11秒前
平静的人完成签到 ,获得积分10
11秒前
孙大伟完成签到,获得积分20
11秒前
吾吾发布了新的文献求助10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180757
求助须知:如何正确求助?哪些是违规求助? 9570857
关于积分的说明 21814590
捐赠科研通 7777053
什么是DOI,文献DOI怎么找? 3433314
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479315